By Alwine Kardinaal, Nutrition & Health Leader at NIZO.
Building strong evidence for an immune health claim is high on the agenda for many in our industry today. In this article, a research expert discusses the process of conducting human clinical trials with this specific aim in mind.
There are over 1,600 human clinical trials on probiotics listed in ClinicalTrials.gov and the WHO’s trial database, according to a new analysis that seeks to address the misconception that there is no human data around probiotics.
As has been reported for other dietary supplement categories, “March was an incredible month” for the omega-3 category, but reports are that those levels have not been maintained through April, said Ellen Schutt, executive director of GOED.
The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has released new guidelines to encourage best practice in clinical trial design and study interpretation.
Out of 11,018 studies conducted on neurological diseases, only 23 examined the effects of probiotics on the diseases. This was less than 1% of all studies done, a review of clinical studies has found.
A more holistic, environmental view of the human gut microbiome is taking shape among researchers, but confounding factors complicate the task of fully elucidating this via tenable study designs.
live from EFSA's 2nd scientific conference, Milan Expo
There is increasing pressure for the European Food Safety Authority (EFSA) to echo the policy of its pharmaceutical cousin the European Medicines Agency (EMA) to publish clinical trials from industry dossiers.
Investment for the design and running of clinical trials is a major expense for the industry, but taking shortcuts to reduce the initial investment needed can be very costly in the long-term, according to one expert.
There’s gold to be found in them health claims mountains, but prospectors from the European Food Safety Authority (EFSA) must be happy with the little chunks that add up to a lot, and stop searching for nuggets the size of your fist.
Apparently conflicting results from randomized clinical trials and observational studies abound in the scientific literature. In the third part of a four-part series on antioxidants, NutraIngredients looks to get behind the contradictions.
